Novartis and Lindy Biosciences sign a licensing and collaboration agreement that will improve biologic delivery. The North Carolina-based biotech company will help deliver biologics via subcutaneous (SC) injections, which can be self-administered at home....

Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a particular focus on life-threatening respiratory infections, has announced that it has completed the Phase 1 clinical...